Literature DB >> 2378355

Genetic epidemiology of hereditary tyrosinemia in Quebec and in Saguenay-Lac-St-Jean.

M De Braekeleer1, J Larochelle.   

Abstract

Hereditary tyrosinemia type I is an autosomal recessive disorder that was recognized in Saguenay-Lac-St-Jean (SLSJ) (Quebec) in 1967. Ninety-eight tyrosinemic children, including some of the 113 children born in the SLSJ region, have been screened by the Quebec Network of Genetic Medicine in the whole province since 1970. The geographical distribution of the 98 children screened showed the majority of them to have been born in the northeastern part of Quebec. The prevalence at birth was estimated at 1/1,846 live borns, and the carrier rate was estimated at 1/20 inhabitants in the SLSJ region. Three control groups matched to the tyrosinemic obligate-carrier couples were generated using the population register of the SLSJ region kept at SOREP. The mean coefficient of inbreeding was only slightly elevated in the tyrosinemic group compared with the control groups and was due to remote consanguinity. The mean kinship coefficient was 2.3 times higher in the tyrosinemic group than in the control groups. In the SLSJ region the places of origin of the tyrosinemic children and their parents did not show a clustered nonuniform distribution. Endogamy was not found to be higher in the tyrosinemic group than in the control groups. All these results support both the hypothesis of a founder effect for tyrosinemia and a high gene frequency in northeastern Quebec.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2378355      PMCID: PMC1683702     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  9 in total

1.  [The first generation of the Saguenay population: origin, kinship, and rootedness].

Authors:  R Roy; G Bouchard; M Declos
Journal:  Cah Que Demogr       Date:  1988

2.  Two methods for measuring the non-randomness of chromosome abnormalities.

Authors:  M De Braekeleer; B Smith
Journal:  Ann Hum Genet       Date:  1988-01       Impact factor: 1.670

3.  Hereditary tyrosinemia in the province of Quebec: prevalence at birth and geographic distribution.

Authors:  P Bergeron; C Laberge; A Grenier
Journal:  Clin Genet       Date:  1974       Impact factor: 4.438

4.  Genetic aspects of tyrosinemia in the Chicoutimi region.

Authors:  C Laberge; L Dallaire
Journal:  Can Med Assoc J       Date:  1967-10-28       Impact factor: 8.262

5.  Experience with 37 infants with tyrosinemia.

Authors:  J Larochelle; A Mortezai; M Belanger; M Tremblay; J C Claveau; G Aubin
Journal:  Can Med Assoc J       Date:  1967-10-28       Impact factor: 8.262

6.  Hereditary tyrosinemia and tyrosyluria: clinical report of four patients.

Authors:  C R Scriver; M Silverberg; C L Clow
Journal:  Can Med Assoc J       Date:  1967-10-28       Impact factor: 8.262

7.  Hereditary tyrosinemia and tyrosyluria in a French Canadian geographic isolate.

Authors:  C R Scriver; J Larochelle; M Silverberg
Journal:  Am J Dis Child       Date:  1967-01

8.  Prenatal diagnosis of hereditary tyrosinaemia: measurement of succinylacetone in amniotic fluid.

Authors:  R Gagné; A Lescault; A Grenier; C Laberge; S B Mélançon; L Dallaire
Journal:  Prenat Diagn       Date:  1982-07       Impact factor: 3.050

9.  On the enzymic defects in hereditary tyrosinemia.

Authors:  B Lindblad; S Lindstedt; G Steen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

  9 in total
  29 in total

1.  Hereditary tyrosinemia type 1 from a single center in Egypt: clinical study of 22 cases.

Authors:  Hanaa El-Karaksy; Mona Fahmy; Mona El-Raziky; Nehal El-Koofy; Rokaya El-Sayed; Mohamed S Rashed; Hasan El-Kiki; Ahmad El-Hennawy; Nabil Mohsen
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

2.  The French Canadian Tay-Sachs disease deletion mutation: identification of probable founders.

Authors:  M De Braekeleer; P Hechtman; E Andermann; F Kaplan
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

Review 3.  The role of nitisinone in tyrosine pathway disorders.

Authors:  Edward Lock; Lakshminarayan R Ranganath; Oliver Timmis
Journal:  Curr Rheumatol Rep       Date:  2014-11       Impact factor: 4.592

4.  Succinylacetone as primary marker to detect tyrosinemia type I in newborns and its measurement by newborn screening programs.

Authors:  Víctor R De Jesús; Barbara W Adam; Daniel Mandel; Carla D Cuthbert; Dietrich Matern
Journal:  Mol Genet Metab       Date:  2014-07-17       Impact factor: 4.797

5.  Imaging features of type 1 hereditary tyrosinemia: a review of 30 patients.

Authors:  J Dubois; L Garel; H Patriquin; K Paradis; S Forget; D Filiatrault; A Grignon; P Russo; D St-Vil
Journal:  Pediatr Radiol       Date:  1996-12

6.  Geographical and Ethnic Distribution of Mutations of the Fumarylacetoacetate Hydrolase Gene in Hereditary Tyrosinemia Type 1.

Authors:  Francesca Angileri; Anne Bergeron; Geneviève Morrow; Francine Lettre; George Gray; Tim Hutchin; Sarah Ball; Robert M Tanguay
Journal:  JIMD Rep       Date:  2015-02-15

7.  Clinical, metabolic, and genetic aspects of cytochrome C oxidase deficiency in Saguenay-Lac-Saint-Jean.

Authors:  C Morin; G Mitchell; J Larochelle; M Lambert; H Ogier; B H Robinson; M De Braekeleer
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

8.  Type 1 hereditary tyrosinemia. Evidence for molecular heterogeneity and identification of a causal mutation in a French Canadian patient.

Authors:  D Phaneuf; M Lambert; R Laframboise; G Mitchell; F Lettre; R M Tanguay
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

Review 9.  Current strategies for the treatment of hereditary tyrosinemia type I.

Authors:  Merja Ashorn; Sari Pitkänen; Matti K Salo; Markku Heikinheimo
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

10.  Genetic epidemiology of sensorimotor polyneuropathy with or without agenesis of the corpus callosum in northeastern Quebec.

Authors:  M De Braekeleer; A Dallaire; J Mathieu
Journal:  Hum Genet       Date:  1993-04       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.